Prospective phase II multi-center study of individualized axitinib (Axi) titration for metastatic renal cell carcinoma (mRCC) after treatment with PD-1 / PD-L1 inhibitors.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 4517-4517 ◽  
Author(s):  
Moshe Chaim Ornstein ◽  
Sumanta K. Pal ◽  
Laura S. Wood ◽  
Kimberly D Allman ◽  
Allison Martin ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Prospective Phase ◽  
Multi Center Study ◽  
Center Study

scholarly journals A Phase II Multi‐Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

2017 ◽  
Vol 22 (8) ◽  
pp. 888 ◽  
Author(s):  
Mauricio Burotto ◽  
Maureen Edgerly ◽  
Margarita Velarde ◽  
Sanjeeve Balasubramaniam ◽  
Harry Drabkin ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Multi Center Study ◽  
Center Study

scholarly journals Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

2018 ◽  
Vol 24 (22) ◽  
pp. 5534-5542 ◽  
Author(s):  
Laetitia Mauge ◽  
Arnaud Mejean ◽  
Laure Fournier ◽  
Helena Pereira ◽  
Marie-Christine Etienne-Grimaldi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Prospective Phase
Sign in / Sign up

Export Citation Format

Share Document